Deutsche Bank Downgrades Argenx Se to Hold

Summary

Deutsche Bank downgraded Argenx SE to ‘hold’ from ‘buy’ due to valuation concerns after the stock rallied over 40% in two months.+ 2

Impact Analysis

So basically, Deutsche Bank is signaling that Argenx SE’s recent stock surge—over 40% in just two months—has pushed its valuation to a point where they see limited upside, hence the downgrade to ‘hold’ from ‘buy’ + 2. This move is interesting because it contrasts with the broader analyst consensus, where 18 out of 19 analysts still rate the stock as a ‘buy’ or ‘strong buy’ . The market might be missing the potential for a pullback if the stock’s valuation doesn’t align with its fundamentals. Despite the downgrade, Argenx’s technical indicators suggest a strong long-term uptrend, with MACD showing a bullish crossover . The trade here could be to watch for any short-term weakness as a buying opportunity, especially if the stock dips closer to its support levels. However, keep an eye on broader market sentiment shifts that could impact healthcare stocks overall.